Navigation Links
Pharmaceutical Preparation Manufacturing Industry in the US and its International Trade [2011 Q3 Edition]
Date:7/21/2011

NEW YORK, July 21, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Pharmaceutical Preparation Manufacturing Industry in the US and its International Trade [2011 Q3 Edition]

http://www.reportlinker.com/p0574385/Pharmaceutical-Preparation-Manufacturing-Industry-in-the-US-and-its-International-Trade-[2011-Q3-Edition].html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_

This latest Pharmaceutical Preparation Manufacturing Industry report provides the most updated market research on the industry. Its scope contains analysis on the industry's key financial data, competitive landscape, shipment and inventory data, upstream and downstream industries, and trade data.

This 2011 report's 174 pages and over 150 charts and tables cover the domestic market, global market and overseas growth opportunities. Find the latest data on shipments, inventory, international trade, and essential industry price indices available through July 2011. Relying on over a decade of historic data and sophisticated forecasting, the report projects industry trends through 2015. The report's broad scope includes topics from foreign trade to industry structure, while also diving into the details such as market sizes of products and players. Industry experts consistently subscribe to this quarterly-updated market research report.

In this report, you will find industry data on the following major categories:

Executive Summary

  • Quick Industry Statistics: 2-page overview for the CEO on the run

  • Supply & Demand with Capacity Utilization

  • 2011-2015 Forecast

Industry Income Statement

  • All relevant financial data including: Revenue, Cost of Materials, Labor Costs, Gross Profit, SG&A, Net Income, etc.

  • 4-year Financials Comparison and Trends

Industry Balance Sheet

  • Traditional key elements of Assets, Liabilities, and Equity

  • Inventory fabrication stages

  • Calculated balance sheet ratios

Capital Expenditure

  • Plant additions and expansions

  • Computer and IT investments

  • Machinery and Equipment for production and material handling

Industry Cost Analysis

  • Upstream Industries and the cost allocations towards producer, wholesale, retail, and freight

  • Materials and their percentage share of total material costs

Industry Pricing Analysis

  • Producer Pricing Indices at industry, wholesale, and retail levels for comparison and trend forecasting

  • Pricing Distribution among Downstream Industries differentiated at producer, wholesale, retail, and freight categories

Industry Foreign Trade

  • Detailed Import/Export Data by commodities and by countries

  • Mode of Shipment and insurance and freight costs

Industry Structure

  • Labor and Compensation Structure: productivity indices, hourly wages, production hours, output index, HR structure

  • Establishments: Trends, Employee Statistics, State by State numbers

  • Valued added statistics: industry GDP contribution

Competitive Landscape

  • Industry Concentration: HHI, number of companies, size distributions, market shares

  • Major Players: company profiles and market size ranges

__________________________________________

Definition & Classification

This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. This 6-digit NAICS industry (325412) is under the hierarchy of Pharmaceutical and Medicine Manufacturing Industry (32541), Chemical Manufacturing Subsector (325), and the Manufacturing Sector (31-33). Its SIC equivalent codes are: 2834 - Pharmaceutical Preparations ; and 2835 - In Vitro and In Vivo Diagnostic Substances (except in-vitro diagnostic substances).

Revenue, Profitability & Foreign Trade Preview

The industry's revenue for the year 2010 was approximately $137.8 billion USD, with an estimated gross profit of 67.29%. Import was valued at $53.4 billion USD from 84 countries. The industry also exported $28.6 billion USD worth of merchandise to 197 countries. Adding import value to and subtracting export value from the industry's shipment value, the total domestic demand for the industry in 2010 was $162.6 billion USD.

Report Summary

This 174-page research report covers the industry with a comprehensive view and delivers a depth of information in key areas. Supply and demand data covers U.S. shipments and international trade in the context of the industry's capacity utilization. Industry level income statements, balance sheets, and capital expenditure analysis allow for financial benchmarking. In the cost analysis section, 52 upstream industries are analyzed to offer insight into the supply chain cost structure. For the channel and pricing structure, 31 downstream industries are analyzed. The competitive landscape section provides the number of companies and their respective revenue share, the market concentration, and a list of major players. Important trade associations, industry standards, and trade publications are also listed. Over 150 labeled charts and tables are organized to best convey the large amount of data within the report.

Our clients include Fortune 500 companies, manufacturers, international top consulting firms, major retailers and wholesalers, professional trade associations, financial corporations, universities, governmental entities, start-ups and individuals. We are committed to providing the highest level of quality to all our clients and assure your satisfaction in the report delivering as promised.

Keywords: adrenal, medicinal, preparations, analgesic, anesthetic, angiourographic, diagnostic, antacid, anthelmintic, antibacterial, antibiotic, antidepressant, antihistamine, antineoplastic, antipyretic, antiseptic, antispasmodic, astringent, barbiturate, barium, vivo, substances, belladonna, birth, control, pills, botanical, extract, except, vitro, diagnostics, cardiac, cathartic, central, nervous, system, stimulant, coagulation, cold, remedies, contraceptive, contrast, media, iodine, cough, drops, medicated, medicines, cyclopropane, dermatological, biological, digestive, digitalis, diuretic, effervescent, salts, electrolyte, eye, ear, fever, remedy, glandular, hematology, hormone, insulin, intravenous, solution, iodinated, laxative, lip, balms, metabolite, mouthwashes, muscle, relaxant, nonprescription, drug, nuclear, medicine, radioactive, isotopes, oral, patent, penicillin, capsules, liniments, ointments, tablets, pituitary, gland, sedative, sodium, chloride, salicylate, suppositories, technetium, thyroid, tincture, tranquilizer, vermifuge, veterinary, vitamin, water, drinking, decontamination, purification, zinc, oxide, abbott, aldrich, allergan, and, bausch, baxter, bristol, cargill, chattem, eli, endo, gamble, genzyme, holdings, hospira, international, johnson, laboratories, lilly, lomb, merck, myers, mylan, nbty, perrigo, pfizer, pharmaceuticals, procter, sigma, squibb, teva, usa

To order this report:

Drug and Medication Industry: Pharmaceutical Preparation Manufacturing Industry in the US and its International Trade [2011 Q3 Edition]

Drug and Medication Business News

More  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Savient Pharmaceuticals to Hold Second Quarter 2011 Financial Results Conference Call on Thursday, August 4, 2011
2. Vanda Pharmaceuticals to Announce Second Quarter 2011 Financial Results on August 4, 2011
3. ReportsnReports - The Outlook for Pharmaceuticals (BRIC, Asia, Europe, E7)
4. Amylin Pharmaceuticals to Webcast Second Quarter Results
5. Valeant Pharmaceuticals Announces Distribution Agreement for Zuacta™ in Canada
6. Unilife Starts Unifill Syringe Sales to Another Pharmaceutical Customer
7. Access Pharmaceuticals MuGard Included in TRICARE Prescription Drug Coverage
8. Auxilium Pharmaceuticals to Announce Second Quarter 2011 Results and Conduct Conference Call on Monday, August 1, 2011
9. ReportsnReports - Rare Earth Elements Market, Healthcare Cold Chain Logistics Market & Pharmaceutical Market Reports
10. Valeant Pharmaceuticals Agrees to Acquire Ortho Dermatologics
11. Janssen Pharmaceuticals, Inc. Announces Definitive Agreement to Divest Ortho Dermatologics Division
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2017)... , Sept. 5, 2017  Just 18 months ... Insight is pleased to announce the appointment of three ... Tammy Wynne , Dominic Jones-Phillips and ... industry. Tammy ... team of market access writers. She has over ten ...
(Date:9/1/2017)... 1, 2017  Bayer will present the latest research from ... Medical Oncology (ESMO) 2017 Congress, September 8-12 in ... preclinical and clinical data on Bayer,s marketed portfolio and late-stage ... "We value the ... cancer research at ESMO," said Carsten Brunn , Head ...
(Date:8/28/2017)... Holdings, Inc. (NYSE: HRC), will present at the Morgan Stanley ... New York . John Greisch , Hill-Rom,s ... 11:05 a.m. Eastern Time. The live audio ... replay will be available one hour after the conclusion of ... About Hill-Rom Holdings, Inc. Hill-Rom ...
Breaking Medicine Technology:
(Date:9/21/2017)... ... September 21, 2017 , ... Preora Diagnostics Inc. ... screening tests, has received two prestigious recognitions that acknowledge the promise of its ... Preora has been named a Top 100 Finalist for the 16th annual ...
(Date:9/21/2017)... ... September 21, 2017 , ... FlipBelt, the fitness brand ... to detail to the athletic wear market with the launch of their FlipBelt Crops. ... have their essentials securely at their fingertips while at the gym, on the trail, ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... Month, Lewis and Clark College Emeritus Professor of Education Gregory A. Smith examines ... of Asleep at the Switch: Schoolhouse Commercialism, Privacy, and the Failure of ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... Coating System for clients that rely on safety and cleanliness. This unique flooring ... , Silver has been used for centuries for its antimicrobial properties. Unlike antibiotics, ...
(Date:9/20/2017)... ... ... Doctors on Liens has added the medical group Bones and Spine Surgery, ... personal injury lien basis. Founded by Dr. Wayne Cheng, MD and Dr. Gordon Yee, ... orthopedic injuries to patients in the Inland Empire. , Bones and Spines Surgery Inc ...
Breaking Medicine News(10 mins):